Athenex Moves Forward With $205M New York Plant Post author:Sam Post published:January 11, 2018 Post category:BioPharma According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace You Might Also Like Mettler-Toledo To Exhibit At Annual Conference In Fort Worth, TX October 8, 2017 Cambridge's Neon Therapeutics Completes $106M Crossover Series B Funding Round December 6, 2017 3 Biotech Stocks Able to Weather an Unstable Administration February 9, 2017